2015
Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study
Achhra A, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith C, Monforte A, Phillips A, Weber R, Lundgren J, Law, Group T. Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Medicine 2015, 17: 255-268. PMID: 26216031, DOI: 10.1111/hiv.12294.Peer-Reviewed Original ResearchConceptsBody mass indexIncidence rate ratiosCardiovascular diseaseART initiationBMI categoriesHistory of CVDAntiretroviral therapy initiationRisk of diabetesTreatment-naïve individualsMain exposure variableLong-term riskPoisson regression modelsDiabetes eventsCD4 countCVD eventsTherapy initiationAdverse eventsCardiometabolic outcomesCohort studyMass indexRisk factorsSubsequent riskNormal rangeDiabetesExposure variables
2012
Race and CD4+ T-cell count in HIV prognosis and treatment
Achhra A, Amin J. Race and CD4+ T-cell count in HIV prognosis and treatment. Future Virology 2012, 7: 193-203. DOI: 10.2217/fvl.11.143.Peer-Reviewed Original ResearchT-cell countsFuture long-term trialsHIV-negative individualsHIV clinical studiesHIV/AIDSLong-term trialsTherapy initiationProspective cohortClinical outcomesHIV prognosisClinical significanceClinical studiesCD4Current evidenceRacial differencesCountRecent studiesDiverse populationsHIVPrognosisTherapyCohortRaceAIDSDifferences